Diffused suberitrodermic psoriasis induced by infliximab

Abstract Views: 834
PDF: 1069
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The case of a young male is described, affected by Crohn disease with reactive Spondoloarthritis essay with Infliximab to the dose of 3 mg/kgs. After 15 days from the 3° infusion, the patient developed a first psoriasic eruption to the palm of the hands and the plant of the feet, for which was begun topical therapy with cortisone. After an initial improvement, the patient introduced a diffusion of the psoriasic eruption to the whole trunk and the limbs with a suberitrodermic aspect. The possible pathogenesis of this paradoxical effect of the anti-TNF is considered. Also being still partly the causes, is important the inhibition of the TNF-alpha with consequent expansion of the INF-alpha, in tum potential inductor of psoriasis.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Bruzzese, V. (2007). Diffused suberitrodermic psoriasis induced by infliximab. Reumatismo, 59(4), 328–331. https://doi.org/10.4081/reumatismo.2007.328